{
  "DOI": "10.1007/s10689-007-9172-6",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-007-9172-6",
  "alternative-id": [
    "9172"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Schrader",
      "given": "Kasmintan A.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Masciari",
      "given": "Serena",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Boyd",
      "given": "Niki",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wiyrick",
      "given": "Sara",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kaurah",
      "given": "Pardeep",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Senz",
      "given": "Janine",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Burke",
      "given": "Wylie",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lynch",
      "given": "Henry T.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Garber",
      "given": "Judy E.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Huntsman",
      "given": "David G.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2007,
        11,
        28
      ]
    ],
    "date-time": "2007-11-28T06:21:09Z",
    "timestamp": 1196230869000
  },
  "deposited": {
    "date-parts": [
      [
        2024,
        2,
        19
      ]
    ],
    "date-time": "2024-02-19T19:42:10Z",
    "timestamp": 1708371730000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        12
      ]
    ],
    "date-time": "2024-04-12T08:27:37Z",
    "timestamp": 1712910457415
  },
  "is-referenced-by-count": 104,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2007,
        11,
        29
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2008,
          3
        ]
      ]
    }
  },
  "language": "en",
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-007-9172-6.pdf",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "73-82",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2007,
        11,
        29
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2007,
        11,
        29
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2008,
        3
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.3748/wjg.v12.i3.354",
      "author": "KD Crew",
      "doi-asserted-by": "crossref",
      "first-page": "354",
      "journal-title": "World J Gastroenterol",
      "key": "9172_CR1",
      "unstructured": "Crew KD, Neugut AI (2006) Epidemiology of gastric cancer. World J Gastroenterol 3:354–362",
      "volume": "3",
      "year": "2006"
    },
    {
      "DOI": "10.5858/2004-128-765-DTITIA",
      "author": "DE Henson",
      "doi-asserted-by": "crossref",
      "first-page": "765",
      "journal-title": "Arch Pathol Lab Med",
      "key": "9172_CR2",
      "unstructured": "Henson DE, Dittus C, Younes M et al (2004) Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973–2000: increase in the signet ring cell type. Arch Pathol Lab Med 7:765–770",
      "volume": "7",
      "year": "2004"
    },
    {
      "DOI": "10.1038/32918",
      "author": "P Guilford",
      "doi-asserted-by": "crossref",
      "first-page": "402",
      "journal-title": "Nature",
      "key": "9172_CR3",
      "unstructured": "Guilford P, Hopkins J, Harraway J et al (1998) E-cadherin germline mutations in familial gastric cancer. Nature 6674:402–405",
      "volume": "6674",
      "year": "1998"
    },
    {
      "DOI": "10.1001/jama.297.21.2360",
      "author": "P Kaurah",
      "doi-asserted-by": "crossref",
      "first-page": "2360",
      "journal-title": "JAMA",
      "key": "9172_CR4",
      "unstructured": "Kaurah P, MacMillan A., Boyd N et al (2007) Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA 21:2360–2372",
      "volume": "21",
      "year": "2007"
    },
    {
      "DOI": "10.1016/S0002-9440(10)65129-2",
      "author": "G Keller",
      "doi-asserted-by": "crossref",
      "first-page": "337",
      "journal-title": "Am J Pathol",
      "key": "9172_CR5",
      "unstructured": "Keller G, Vogelsang H, Becker I et al (1999) Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am J Pathol 2:337–342",
      "volume": "2",
      "year": "1999"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-05-0247",
      "author": "G Suriano",
      "doi-asserted-by": "crossref",
      "first-page": "5401",
      "journal-title": "Clin Cancer Res",
      "key": "9172_CR6",
      "unstructured": "Suriano G, Yew S, Ferreira P et al (2005) Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management. Clin Cancer Res 15:5401–5409",
      "volume": "15",
      "year": "2005"
    },
    {
      "DOI": "10.1002/humu.10068",
      "author": "C Oliveira",
      "doi-asserted-by": "crossref",
      "first-page": "510",
      "journal-title": "Hum Mutat",
      "key": "9172_CR7",
      "unstructured": "Oliveira C, Bordin MC, Grehan N et al (2002) Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred. Hum Mutat 5:510–517",
      "volume": "5",
      "year": "2002"
    },
    {
      "DOI": "10.1136/jmg.2004.018275",
      "author": "AR Brooks-Wilson",
      "doi-asserted-by": "crossref",
      "first-page": "508",
      "journal-title": "J Med Genet",
      "key": "9172_CR8",
      "unstructured": "Brooks-Wilson AR, Kaurah P, Suriano G et al (2004) Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet 7:508–517",
      "volume": "7",
      "year": "2004"
    },
    {
      "DOI": "10.1136/jmg.2007.051268",
      "author": "S Masciari",
      "doi-asserted-by": "crossref",
      "first-page": "726",
      "journal-title": "J Med Genet",
      "key": "9172_CR9",
      "unstructured": "Masciari S, Larsson N, Senz J et al (2007) Germline E-Cadherin mutations in familial lobular breast cancer. J Med Genet 44:726–731",
      "volume": "44",
      "year": "2007"
    },
    {
      "DOI": "10.1093/annonc/mdg486",
      "author": "F Graziano",
      "doi-asserted-by": "crossref",
      "first-page": "1705",
      "journal-title": "Ann Oncol",
      "key": "9172_CR10",
      "unstructured": "Graziano F, Humar B, Guilford P (2003) The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice. Ann Oncol 12:1705–1713",
      "volume": "12",
      "year": "2003"
    },
    {
      "DOI": "10.1002/(SICI)1098-1004(1998)12:4\u003c226::AID-HUMU2\u003e3.0.CO;2-D",
      "author": "G Berx",
      "doi-asserted-by": "crossref",
      "first-page": "226",
      "journal-title": "Hum Mutat",
      "key": "9172_CR11",
      "unstructured": "Berx G, Becker KF, Hofler H et al (1998) Mutations of the human E-cadherin (CDH1) gene. Hum Mutat 4:226–237",
      "volume": "4",
      "year": "1998"
    },
    {
      "DOI": "10.1002/(SICI)1097-4644(19960616)61:4\u003c514::AID-JCB4\u003e3.0.CO;2-R",
      "author": "H Aberle",
      "doi-asserted-by": "crossref",
      "first-page": "514",
      "journal-title": "J Cell Biochem",
      "key": "9172_CR12",
      "unstructured": "Aberle H, Schwartz H, Kemler R (1996) Cadherin-catenin complex: protein interactions and their implications for cadherin function. J Cell Biochem 4:514–523",
      "volume": "4",
      "year": "1996"
    },
    {
      "DOI": "10.1083/jcb.148.1.189",
      "author": "MA Thoreson",
      "doi-asserted-by": "crossref",
      "first-page": "189",
      "journal-title": "J Cell Biol",
      "key": "9172_CR13",
      "unstructured": "Thoreson MA, Anastasiadis PZ, Daniel JM et al (2000) Selective uncoupling of p120(ctn) from E-cadherin disrupts strong adhesion. J Cell Biol 1:189–202",
      "volume": "1",
      "year": "2000"
    },
    {
      "DOI": "10.1016/j.bbamcr.2006.07.005",
      "author": "K Xiao",
      "doi-asserted-by": "crossref",
      "first-page": "8",
      "journal-title": "Biochim Biophys Acta",
      "key": "9172_CR14",
      "unstructured": "Xiao K, Oas RG, Chiasson CM et al (2007) Role of p120-catenin in cadherin trafficking. Biochim Biophys Acta 1:8–16",
      "volume": "1",
      "year": "2007"
    },
    {
      "DOI": "10.1016/0092-8674(91)90143-M",
      "author": "K Vleminckx",
      "doi-asserted-by": "crossref",
      "first-page": "107",
      "journal-title": "Cell",
      "key": "9172_CR15",
      "unstructured": "Vleminckx K, Vakaet L Jr, Mareel M et al (1991) Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1:107–119",
      "volume": "1",
      "year": "1991"
    },
    {
      "DOI": "10.1046/j.1365-2168.2000.01513.x",
      "author": "BP Wijnhoven",
      "doi-asserted-by": "crossref",
      "first-page": "992",
      "journal-title": "Br J Surg",
      "key": "9172_CR16",
      "unstructured": "Wijnhoven BP, Dinjens WN, Pignatelli M (2000) E-cadherin-catenin cell–cell adhesion complex and human cancer. Br J Surg 8:992–1005",
      "volume": "8",
      "year": "2000"
    },
    {
      "DOI": "10.1007/s000180050449",
      "author": "A Novak",
      "doi-asserted-by": "crossref",
      "first-page": "523",
      "journal-title": "Cell Mol Life Sci",
      "key": "9172_CR17",
      "unstructured": "Novak A, Dedhar S (1999) Signaling through beta-catenin and Lef/Tcf. Cell Mol Life Sci 5–6:523–537",
      "volume": "5–6",
      "year": "1999"
    },
    {
      "DOI": "10.1242/jcs.112.8.1237",
      "author": "S Orsulic",
      "doi-asserted-by": "crossref",
      "first-page": "1237",
      "journal-title": "J Cell Sci",
      "key": "9172_CR18",
      "unstructured": "Orsulic S, Huber O, Aberle H et al (1999) E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation. J Cell Sci Pt 8:1237–1245",
      "volume": "Pt 8",
      "year": "1999"
    },
    {
      "DOI": "10.1242/jcs.03485",
      "author": "K Aoki",
      "doi-asserted-by": "crossref",
      "first-page": "3327",
      "journal-title": "J Cell Sci",
      "key": "9172_CR19",
      "unstructured": "Aoki K, Taketo MM (2007) Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene. J Cell Sci Pt 19:3327–3335",
      "volume": "Pt 19",
      "year": "2007"
    },
    {
      "DOI": "10.1002/path.1564",
      "author": "F Carneiro",
      "doi-asserted-by": "crossref",
      "first-page": "681",
      "journal-title": "J Pathol",
      "key": "9172_CR20",
      "unstructured": "Carneiro F, Huntsman DG, Smyrk TC et al (2004) Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol 2:681–687",
      "volume": "2",
      "year": "2004"
    },
    {
      "DOI": "10.1002/(SICI)1096-9896(199712)183:4\u003c404::AID-PATH1148\u003e3.0.CO;2-9",
      "author": "WJ Leeuw De",
      "doi-asserted-by": "crossref",
      "first-page": "404",
      "journal-title": "J Pathol",
      "key": "9172_CR21",
      "unstructured": "De Leeuw WJ, Berx G, Vos CB et al (1997) Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 4:404–411",
      "volume": "4",
      "year": "1997"
    },
    {
      "author": "KF Becker",
      "first-page": "3845",
      "journal-title": "Cancer Res",
      "key": "9172_CR22",
      "unstructured": "Becker KF, Atkinson MJ, Reich U et al (1994) E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 14:3845–3852",
      "volume": "14",
      "year": "1994"
    },
    {
      "DOI": "10.1093/jnci/87.14.1082",
      "author": "KF Becker",
      "doi-asserted-by": "crossref",
      "first-page": "1082",
      "journal-title": "J Natl Cancer Inst",
      "key": "9172_CR23",
      "unstructured": "Becker KF, Hofler H (1995) Frequent somatic allelic inactivation of the E-cadherin gene in gastric carcinomas. J Natl Cancer Inst 14:1082–1084",
      "volume": "14",
      "year": "1995"
    },
    {
      "author": "JC Machado",
      "first-page": "459",
      "journal-title": "Lab Invest",
      "key": "9172_CR24",
      "unstructured": "Machado JC, Soares P, Carneiro F et al (1999) E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. Lab Invest 79:459–465",
      "volume": "79",
      "year": "1999"
    },
    {
      "DOI": "10.1136/jcp.2006.043679",
      "doi-asserted-by": "crossref",
      "key": "9172_CR25",
      "unstructured": "Carneiro F, Oliveira C, Suriano G et al (2007) Molecular pathology of familial gastric cancer. J. Clin. Pathol"
    },
    {
      "DOI": "10.1038/79120",
      "author": "WM Grady",
      "doi-asserted-by": "crossref",
      "first-page": "16",
      "journal-title": "Nat Genet",
      "key": "9172_CR26",
      "unstructured": "Grady WM, Willis J, Guilford PJ et al (2000) Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet 1:16–17",
      "volume": "1",
      "year": "2000"
    },
    {
      "DOI": "10.1634/theoncologist.9-1-13",
      "author": "DL Thull",
      "doi-asserted-by": "crossref",
      "first-page": "13",
      "journal-title": "Oncologist",
      "key": "9172_CR27",
      "unstructured": "Thull DL, Vogel VG (2004) Recognition and management of hereditary breast cancer syndromes. Oncologist 1:13–24",
      "volume": "1",
      "year": "2004"
    },
    {
      "DOI": "10.1007/s11864-007-0021-5",
      "author": "DS Rosman",
      "doi-asserted-by": "crossref",
      "first-page": "61",
      "journal-title": "Curr Treat Options Oncol",
      "key": "9172_CR28",
      "unstructured": "Rosman DS, Kaklamani V, Pasche B (2007) New insights into breast cancer genetics and impact on patient management. Curr Treat Options Oncol 1:61–73",
      "volume": "1",
      "year": "2007"
    },
    {
      "author": "CHEK2 Breast Cancer Case-Control Consortium",
      "first-page": "1175",
      "journal-title": "Am J Hum Genet",
      "key": "9172_CR29",
      "unstructured": "CHEK2 Breast Cancer Case-Control Consortium (2004) CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. Am J Hum Genet 6:1175–1182",
      "volume": "6",
      "year": "2004"
    },
    {
      "DOI": "10.1038/ng1902",
      "author": "S Seal",
      "doi-asserted-by": "crossref",
      "first-page": "1239",
      "journal-title": "Nat Genet",
      "key": "9172_CR30",
      "unstructured": "Seal S, Thompson D, Renwick A et al (2006) Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet 11:1239–1241",
      "volume": "11",
      "year": "2006"
    },
    {
      "DOI": "10.1038/ng1959",
      "author": "N Rahman",
      "doi-asserted-by": "crossref",
      "first-page": "165",
      "journal-title": "Nat Genet",
      "key": "9172_CR31",
      "unstructured": "Rahman N, Seal S, Thompson D et al (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 2:165–167",
      "volume": "2",
      "year": "2007"
    },
    {
      "DOI": "10.1038/sj.onc.1209873",
      "author": "M Ahmed",
      "doi-asserted-by": "crossref",
      "first-page": "5906",
      "journal-title": "Oncogene",
      "key": "9172_CR32",
      "unstructured": "Ahmed M, Rahman N (2006) ATM and breast cancer susceptibility. Oncogene 43:5906–5911",
      "volume": "43",
      "year": "2006"
    },
    {
      "DOI": "10.1186/bcr767",
      "author": "G Arpino",
      "doi-asserted-by": "crossref",
      "first-page": "R149",
      "journal-title": "Breast Cancer Res",
      "key": "9172_CR33",
      "unstructured": "Arpino G, Bardou VJ, Clark GM et al (2004) Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res 3:R149–156",
      "volume": "3",
      "year": "2004"
    },
    {
      "DOI": "10.1002/ijc.21236",
      "author": "K Allen-Brady",
      "doi-asserted-by": "crossref",
      "first-page": "655",
      "journal-title": "Int J Cancer",
      "key": "9172_CR34",
      "unstructured": "Allen-Brady K, Camp NJ, Ward JH et al (2005) Lobular breast cancer: excess familiality observed in the Utah Population Database. Int J Cancer 4:655–661",
      "volume": "4",
      "year": "2005"
    },
    {
      "author": "SR Lakhani",
      "first-page": "782",
      "journal-title": "Clin Cancer Res",
      "key": "9172_CR35",
      "unstructured": "Lakhani SR, Gusterson BA, Jacquemier J et al (2000) The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. Clin Cancer Res 3:782–789",
      "volume": "3",
      "year": "2000"
    },
    {
      "author": "R Moll",
      "first-page": "1731",
      "journal-title": "Am J Pathol",
      "key": "9172_CR36",
      "unstructured": "Moll R, Mitze M, Frixen UH et al (1993) Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 6:1731–1742",
      "volume": "6",
      "year": "1993"
    },
    {
      "DOI": "10.1186/bcr309",
      "author": "G Berx",
      "doi-asserted-by": "crossref",
      "first-page": "289",
      "journal-title": "Breast Cancer Res",
      "key": "9172_CR37",
      "unstructured": "Berx G, Van Roy F (2001) The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res 5:289–293",
      "volume": "5",
      "year": "2001"
    },
    {
      "author": "G Berx",
      "first-page": "1919",
      "journal-title": "Oncogene",
      "key": "9172_CR38",
      "unstructured": "Berx G, Cleton-Jansen AM, Strumane K et al (1996) E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 9:1919–1925",
      "volume": "9",
      "year": "1996"
    },
    {
      "DOI": "10.1002/j.1460-2075.1995.tb00301.x",
      "author": "G Berx",
      "doi-asserted-by": "crossref",
      "first-page": "6107",
      "journal-title": "EMBO J",
      "key": "9172_CR39",
      "unstructured": "Berx G, Cleton-Jansen AM, Nollet F et al (1995) E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 24:6107–6115",
      "volume": "24",
      "year": "1995"
    },
    {
      "DOI": "10.1002/ijc.1208",
      "author": "S Droufakou",
      "doi-asserted-by": "crossref",
      "first-page": "404",
      "journal-title": "Int J Cancer",
      "key": "9172_CR40",
      "unstructured": "Droufakou S, Deshmane V, Roylance R et al (2001) Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast. Int J Cancer 3:404–408",
      "volume": "3",
      "year": "2001"
    },
    {
      "DOI": "10.1038/sj.onc.1204234",
      "author": "JC Machado",
      "doi-asserted-by": "crossref",
      "first-page": "1525",
      "journal-title": "Oncogene",
      "key": "9172_CR41",
      "unstructured": "Machado JC, Oliveira C, Carvalho R et al (2001) E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 12:1525–1528",
      "volume": "12",
      "year": "2001"
    },
    {
      "DOI": "10.1002/humu.10067",
      "author": "B Humar",
      "doi-asserted-by": "crossref",
      "first-page": "518",
      "journal-title": "Hum Mutat",
      "key": "9172_CR42",
      "unstructured": "Humar B, Toro T, Graziano F et al (2002) Novel germline CDH1 mutations in hereditary diffuse gastric cancer families. Hum Mutat 5:518–525",
      "volume": "5",
      "year": "2002"
    },
    {
      "DOI": "10.1002/ijc.11197",
      "author": "D Sarrio",
      "doi-asserted-by": "crossref",
      "first-page": "208",
      "journal-title": "Int J Cancer",
      "key": "9172_CR43",
      "unstructured": "Sarrio D, Moreno-Bueno G, Hardisson D et al (2003) Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability. Int J Cancer 2:208–215",
      "volume": "2",
      "year": "2003"
    },
    {
      "DOI": "10.1054/bjoc.1999.0965",
      "author": "N Rahman",
      "doi-asserted-by": "crossref",
      "first-page": "568",
      "journal-title": "Br J Cancer",
      "key": "9172_CR44",
      "unstructured": "Rahman N, Stone JG, Coleman G et al (2000) Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene. Br J Cancer 3:568–570",
      "volume": "3",
      "year": "2000"
    },
    {
      "DOI": "10.1186/bcr295",
      "author": "S Salahshor",
      "doi-asserted-by": "crossref",
      "first-page": "199",
      "journal-title": "Breast Cancer Res",
      "key": "9172_CR45",
      "unstructured": "Salahshor S, Haixin L, Huo H et al (2001) Low frequency of E-cadherin alterations in familial breast cancer. Breast Cancer Res 3:199–207",
      "volume": "3",
      "year": "2001"
    },
    {
      "DOI": "10.1002/ijc.10176",
      "author": "H Lei",
      "doi-asserted-by": "crossref",
      "first-page": "199",
      "journal-title": "Int J Cancer",
      "key": "9172_CR46",
      "unstructured": "Lei H, Sjoberg-Margolin S, Salahshor S et al (2002) CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer risk. Int J Cancer 2:199–204",
      "volume": "2",
      "year": "2002"
    },
    {
      "DOI": "10.1053/gast.2001.29611",
      "author": "PD Pharoah",
      "doi-asserted-by": "crossref",
      "first-page": "1348",
      "journal-title": "Gastroenterology",
      "key": "9172_CR47",
      "unstructured": "Pharoah PD, Guilford P, Caldas C et al (2001) Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 6:1348–1353",
      "volume": "6",
      "year": "2001"
    },
    {
      "DOI": "10.1056/NEJM198902233200802",
      "author": "B Fisher",
      "doi-asserted-by": "crossref",
      "first-page": "479",
      "journal-title": "N Engl J Med",
      "key": "9172_CR48",
      "unstructured": "Fisher B, Costantino J, Redmond C et al (1989) A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 8:479–484",
      "volume": "8",
      "year": "1989"
    },
    {
      "DOI": "10.1001/jama.295.23.joc60075",
      "author": "SR Land",
      "doi-asserted-by": "crossref",
      "first-page": "2742",
      "journal-title": "JAMA",
      "key": "9172_CR49",
      "unstructured": "Land SR, Wickerham DL, Costantino JP et al (2006) Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 23:2742–2751",
      "volume": "23",
      "year": "2006"
    },
    {
      "DOI": "10.1111/j.1749-6632.2001.tb04007.x",
      "doi-asserted-by": "crossref",
      "key": "9172_CR50",
      "unstructured": "Wolmark N, Dunn BK (2001) The role of tamoxifen in breast cancer prevention: issues sparked by the NSABP Breast Cancer Prevention Trial (P-1). Ann NY Acad Sci 99–108"
    },
    {
      "DOI": "10.1200/JCO.2004.04.188",
      "author": "TR Rebbeck",
      "doi-asserted-by": "crossref",
      "first-page": "1055",
      "journal-title": "J Clin Oncol",
      "key": "9172_CR51",
      "unstructured": "Rebbeck TR, Friebel T, Lynch HT et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 6:1055–1062",
      "volume": "6",
      "year": "2004"
    },
    {
      "DOI": "10.1002/cncr.20728",
      "author": "M Robson",
      "doi-asserted-by": "crossref",
      "first-page": "44",
      "journal-title": "Cancer",
      "key": "9172_CR52",
      "unstructured": "Robson M, Svahn T, McCormick B et al (2005) Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: a clinic-based series. Cancer 1:44–51",
      "volume": "1",
      "year": "2005"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-04-0599",
      "author": "MC Kouwen van",
      "doi-asserted-by": "crossref",
      "first-page": "6456",
      "journal-title": "Clin Cancer Res",
      "key": "9172_CR53",
      "unstructured": "van Kouwen MC, Drenth JP, Oye WJ et al (2004) [18F]Fluoro-2-deoxy-d-glucose positron emission tomography detects gastric carcinoma in an early stage in an asymptomatic E-cadherin mutation carrier. Clin Cancer Res 19:6456–6459",
      "volume": "19",
      "year": "2004"
    },
    {
      "DOI": "10.1136/gut.2004.049171",
      "author": "D Shaw",
      "doi-asserted-by": "crossref",
      "first-page": "461",
      "journal-title": "Gut",
      "key": "9172_CR54",
      "unstructured": "Shaw D, Blair V, Framp A et al (2005) Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy? Gut 4:461–468",
      "volume": "4",
      "year": "2005"
    },
    {
      "DOI": "10.1056/NEJM200106213442504",
      "author": "DG Huntsman",
      "doi-asserted-by": "crossref",
      "first-page": "1904",
      "journal-title": "N Engl J Med",
      "key": "9172_CR55",
      "unstructured": "Huntsman DG, Carneiro F, Lewis FR et al (2001) Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med 25:1904–1909",
      "volume": "25",
      "year": "2001"
    },
    {
      "DOI": "10.1097/01.sla.0000254370.29893.e4",
      "author": "JA Norton",
      "doi-asserted-by": "crossref",
      "first-page": "873",
      "journal-title": "Ann Surg",
      "key": "9172_CR56",
      "unstructured": "Norton JA, Ham CM, Van Dam J et al (2007) CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer. Ann Surg 6:873–879",
      "volume": "6",
      "year": "2007"
    },
    {
      "DOI": "10.1002/jso.20214",
      "author": "HT Lynch",
      "doi-asserted-by": "crossref",
      "first-page": "114",
      "journal-title": "J Surg Oncol",
      "key": "9172_CR57",
      "unstructured": "Lynch HT, Grady W, Suriano G et al (2005) Gastric cancer: new genetic developments. J Surg Oncol 3:114–133; discussion 133",
      "volume": "3",
      "year": "2005"
    },
    {
      "DOI": "10.1126/science.1133427",
      "author": "T Sjoblom",
      "doi-asserted-by": "crossref",
      "first-page": "268",
      "journal-title": "Science",
      "key": "9172_CR58",
      "unstructured": "Sjoblom T, Jones S, Wood LD et al (2006) The consensus coding sequences of human breast and colorectal cancers. Science 5797:268–274",
      "volume": "5797",
      "year": "2006"
    },
    {
      "DOI": "10.1086/375033",
      "author": "A Antoniou",
      "doi-asserted-by": "crossref",
      "first-page": "1117",
      "journal-title": "Am J Hum Genet",
      "key": "9172_CR59",
      "unstructured": "Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 5:1117–1130",
      "volume": "5",
      "year": "2003"
    },
    {
      "DOI": "10.1038/sj.bjc.6600562",
      "author": "A Jakubowska",
      "doi-asserted-by": "crossref",
      "first-page": "888",
      "journal-title": "Br J Cancer",
      "key": "9172_CR60",
      "unstructured": "Jakubowska A, Nej K, Huzarski T et al (2002) BRCA2 gene mutations in families with aggregations of breast and stomach cancers. Br J Cancer 8:888–891",
      "volume": "8",
      "year": "2002"
    },
    {
      "DOI": "10.1093/jnci/91.15.1310",
      "doi-asserted-by": "crossref",
      "key": "9172_CR61",
      "unstructured": "Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium (1999) J Natl Cancer Inst 15:1310–1316"
    },
    {
      "DOI": "10.1054/bjoc.2000.1605",
      "author": "A Figer",
      "doi-asserted-by": "crossref",
      "first-page": "478",
      "journal-title": "Br J Cancer",
      "key": "9172_CR62",
      "unstructured": "Figer A, Irmin L, Geva R et al (2001) The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in Israel. Br J Cancer 4:478–481",
      "volume": "4",
      "year": "2001"
    },
    {
      "DOI": "10.1086/318787",
      "author": "HA Risch",
      "doi-asserted-by": "crossref",
      "first-page": "700",
      "journal-title": "Am J Hum Genet",
      "key": "9172_CR63",
      "unstructured": "Risch HA, McLaughlin JR, Cole DE et al (2001) Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 3:700–710",
      "volume": "3",
      "year": "2001"
    },
    {
      "DOI": "10.1093/jnci/94.18.1365",
      "author": "MS Brose",
      "doi-asserted-by": "crossref",
      "first-page": "1365",
      "journal-title": "J Natl Cancer Inst",
      "key": "9172_CR64",
      "unstructured": "Brose MS, Rebbeck TR, Calzone KA et al (2002) Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst 18:1365–1372",
      "volume": "18",
      "year": "2002"
    },
    {
      "DOI": "10.1053/gast.2000.20228",
      "author": "FM Giardiello",
      "doi-asserted-by": "crossref",
      "first-page": "1447",
      "journal-title": "Gastroenterology",
      "key": "9172_CR65",
      "unstructured": "Giardiello FM, Brensinger JD, Tersmette AC, Goodman SN, Petersen GM, Booker SV, Cruz-Correa M, Offerhaus JA (2000) Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 6:1447–1453",
      "volume": "6",
      "year": "2000"
    },
    {
      "DOI": "10.1111/j.1399-0004.1986.tb00816.x",
      "author": "TM Starink",
      "doi-asserted-by": "crossref",
      "first-page": "222",
      "journal-title": "Clin Genet",
      "key": "9172_CR66",
      "unstructured": "Starink TM, van der Veen JP, Arwert F et al (1986) The Cowden syndrome: a clinical and genetic study in 21 patients. Clin Genet 3:222–233",
      "volume": "3",
      "year": "1986"
    },
    {
      "DOI": "10.1002/1097-0142(197806)41:6\u003c2393::AID-CNCR2820410644\u003e3.0.CO;2-K",
      "author": "M.H. Brownstein",
      "doi-asserted-by": "crossref",
      "first-page": "2393",
      "journal-title": "Cancer",
      "key": "9172_CR67",
      "unstructured": "Brownstein M.H., Wolf M., Bikowski J.B. (1978) Cowden’s disease: a cutaneous marker of breast cancer. Cancer 6:2393–2398",
      "volume": "6",
      "year": "1978"
    },
    {
      "DOI": "10.1016/S0039-6060(05)80018-2",
      "author": "LS Hamby",
      "doi-asserted-by": "crossref",
      "first-page": "115",
      "journal-title": "Surgery",
      "key": "9172_CR68",
      "unstructured": "Hamby LS, Lee EY, Schwartz RW (1995) Parathyroid adenoma and gastric carcinoma as manifestations of Cowden’s disease. Surgery 1:115–117",
      "volume": "1",
      "year": "1995"
    },
    {
      "DOI": "10.1038/sj.onc.1204621",
      "author": "JM Birch",
      "doi-asserted-by": "crossref",
      "first-page": "4621",
      "journal-title": "Oncogene",
      "key": "9172_CR69",
      "unstructured": "Birch JM, Alston RD, McNally RJ et al (2001) Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 34:4621–4628",
      "volume": "34",
      "year": "2001"
    },
    {
      "DOI": "10.1136/jmg.38.1.43",
      "author": "A Chompret",
      "doi-asserted-by": "crossref",
      "first-page": "43",
      "journal-title": "J Med Genet",
      "key": "9172_CR70",
      "unstructured": "Chompret A, Abel A, Stoppa-Lyonnet D et al (2001) Sensitivity and predictive value of criteria for p53 germline mutation screening. J Med Genet 1:43–47",
      "volume": "1",
      "year": "2001"
    },
    {
      "DOI": "10.1136/jmg.2003.015594",
      "author": "G Keller",
      "doi-asserted-by": "crossref",
      "first-page": "e89",
      "journal-title": "J Med Genet",
      "key": "9172_CR71",
      "unstructured": "Keller G, Vogelsang H, Becker I et al (2004) Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1:contribute to genetic predisposition in German gastric cancer patients. J Med Genet 6:e89",
      "volume": "6",
      "year": "2004"
    },
    {
      "DOI": "10.1007/s10038-004-0193-9",
      "author": "IJ Kim",
      "doi-asserted-by": "crossref",
      "first-page": "591",
      "journal-title": "J Hum Genet",
      "key": "9172_CR72",
      "unstructured": "Kim IJ, Kang HC, Shin Y et al (2004) A TP53-truncating germline mutation (E287X) in a family with characteristics of both hereditary diffuse gastric cancer and Li-Fraumeni syndrome. J Hum Genet 49:591–595",
      "volume": "49",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.ejca.2004.04.027",
      "author": "C Oliveira",
      "doi-asserted-by": "crossref",
      "first-page": "1897",
      "journal-title": "Eur J Cancer",
      "key": "9172_CR73",
      "unstructured": "Oliveira C, Ferreira P, Nabais S et al (2004) E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients. Eur J Cancer 12:1897–1903",
      "volume": "12",
      "year": "2004"
    },
    {
      "DOI": "10.1111/j.1349-7006.2000.tb01028.x",
      "author": "K Kimura",
      "doi-asserted-by": "crossref",
      "first-page": "875",
      "journal-title": "Jpn J Cancer Res",
      "key": "9172_CR74",
      "unstructured": "Kimura K, Shinmura K, Yoshimura K et al (2000) Absence of germline CHK2 mutations in familial gastric cancer. Jpn J Cancer Res 9:875–879",
      "volume": "9",
      "year": "2000"
    },
    {
      "DOI": "10.1023/B:DDAS.0000017448.58196.dc",
      "author": "S Shimoyama",
      "doi-asserted-by": "crossref",
      "first-page": "260",
      "journal-title": "Dig Dis Sci",
      "key": "9172_CR75",
      "unstructured": "Shimoyama S, Aoki F, Kawahara M et al (2004) Early gastric cancer development in a familial adenomatous polyposis patient. Dig Dis Sci 2:260–265",
      "volume": "2",
      "year": "2004"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-04-0597",
      "author": "E Dulaimi",
      "doi-asserted-by": "crossref",
      "first-page": "6189",
      "issue": "Pt 1",
      "journal-title": "Clin Cancer Res",
      "key": "9172_CR76",
      "unstructured": "Dulaimi E, Hillinck J, Ibanez de Caceres I et al (2004) Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients. Clin Cancer Res 18(Pt 1):6189–6193",
      "volume": "18",
      "year": "2004"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-04-1810",
      "author": "M Shinozaki",
      "doi-asserted-by": "crossref",
      "first-page": "2156",
      "journal-title": "Clin Cancer Res",
      "key": "9172_CR77",
      "unstructured": "Shinozaki M, Hoon DS, Giuliano AE et al (2005) Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis. Clin Cancer Res 6:2156–2162",
      "volume": "6",
      "year": "2005"
    },
    {
      "DOI": "10.1007/s10689-006-9000-4",
      "doi-asserted-by": "crossref",
      "key": "9172_CR78",
      "unstructured": "Geary J, Sasieni P, Houlston R et al (2007) Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC). Fam Cancer"
    },
    {
      "DOI": "10.1002/(SICI)1097-0142(19960501)77:9\u003c1836::AID-CNCR12\u003e3.0.CO;2-0",
      "author": "JI Risinger",
      "doi-asserted-by": "crossref",
      "first-page": "1836",
      "journal-title": "Cancer",
      "key": "9172_CR79",
      "unstructured": "Risinger JI, Barrett JC, Watson P et al (1996) Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer 9:1836–1843",
      "volume": "9",
      "year": "1996"
    },
    {
      "DOI": "10.1086/316942",
      "author": "RJ Scott",
      "doi-asserted-by": "crossref",
      "first-page": "118",
      "journal-title": "Am J Hum Genet",
      "key": "9172_CR80",
      "unstructured": "Scott RJ, McPhillips M, Meldrum CJ et al (2001) Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet 1:118–127",
      "volume": "1",
      "year": "2001"
    },
    {
      "DOI": "10.1016/j.humpath.2005.08.025",
      "author": "PJ Westenend",
      "doi-asserted-by": "crossref",
      "first-page": "1322",
      "journal-title": "Hum Pathol",
      "key": "9172_CR81",
      "unstructured": "Westenend PJ, Schutte R, Hoogmans MM et al (2005) Breast cancer in an MSH2 gene mutation carrier. Hum Pathol 12:1322–1326",
      "volume": "12",
      "year": "2005"
    },
    {
      "author": "I Spagnoletti",
      "first-page": "845",
      "journal-title": "Oncol Rep",
      "key": "9172_CR82",
      "unstructured": "Spagnoletti I, Pizzi C, Galietta A et al (2004) Loss of hMSH2 expression in primary breast cancer with p53 alterations. Oncol Rep 4:845–851",
      "volume": "4",
      "year": "2004"
    },
    {
      "DOI": "10.1001/jama.1969.03160360030006",
      "author": "AF Haerer",
      "doi-asserted-by": "crossref",
      "first-page": "1884",
      "journal-title": "JAMA",
      "key": "9172_CR83",
      "unstructured": "Haerer AF, Jackson JF, Evers CG (1969) Ataxia-telangiectasia with gastric adenocarcinoma. JAMA 10:1884–1887",
      "volume": "10",
      "year": "1969"
    },
    {
      "DOI": "10.1620/tjem.121.127",
      "author": "A Watanabe",
      "doi-asserted-by": "crossref",
      "first-page": "127",
      "journal-title": "Tohoku J Exp Med",
      "key": "9172_CR84",
      "unstructured": "Watanabe A, Hanazono H, Sogawa H et al (1977) Stomach cancer of a 14-year-old boy with ataxia-telangiectasia. Tohoku J Exp Med 2:127–131",
      "volume": "2",
      "year": "1977"
    },
    {
      "author": "WL Bigbee",
      "first-page": "402",
      "journal-title": "Am J Hum Genet",
      "key": "9172_CR85",
      "unstructured": "Bigbee WL, Langlois RG, Swift M et al (1989) Evidence for an elevated frequency of in vivo somatic cell mutations in ataxia telangiectasia. Am J Hum Genet 3:402–408",
      "volume": "3",
      "year": "1989"
    },
    {
      "DOI": "10.1093/jnci/dji141",
      "author": "D Thompson",
      "doi-asserted-by": "crossref",
      "first-page": "813",
      "journal-title": "J Natl Cancer Inst",
      "key": "9172_CR86",
      "unstructured": "Thompson D, Duedal S, Kirner J et al (2005) Cancer risks and mortality in heterozygous ATM mutation carriers. J Natl Cancer Inst 11:813–822",
      "volume": "11",
      "year": "2005"
    },
    {
      "DOI": "10.1136/pgmj.70.821.240-a",
      "author": "Y Milo",
      "doi-asserted-by": "crossref",
      "first-page": "240",
      "journal-title": "Postgrad Med J",
      "key": "9172_CR87",
      "unstructured": "Milo Y, Deutsch AA, Zahavi S et al (1994) Xeroderma pigmentosum with recurrent infiltrating ductal carcinoma of breast. Postgrad Med J 821:240–241",
      "volume": "821",
      "year": "1994"
    },
    {
      "DOI": "10.1111/j.1365-2133.1985.tb02394.x",
      "author": "L Puig",
      "doi-asserted-by": "crossref",
      "first-page": "632",
      "journal-title": "Br J Dermatol",
      "key": "9172_CR88",
      "unstructured": "Puig L, Marti R, Matias-Guiu X et al (1985) Gastric adenocarcinoma in a patient with xeroderma pigmentosum. Br J Dermatol 5:632–633",
      "volume": "5",
      "year": "1985"
    },
    {
      "DOI": "10.1093/oxfordjournals.jjco.a039443",
      "author": "H Tsuchiya",
      "doi-asserted-by": "crossref",
      "first-page": "135",
      "journal-title": "Jpn J Clin Oncol",
      "key": "9172_CR89",
      "unstructured": "Tsuchiya H, Tomita K, Ohno M et al (1991) Werner’s syndrome combined with quintuplicate malignant tumors: a case report and review of literature data. Jpn J Clin Oncol 2:135–142",
      "volume": "2",
      "year": "1991"
    },
    {
      "author": "M Wirtenberger",
      "first-page": "1655",
      "journal-title": "Carcinogenesis",
      "key": "9172_CR90",
      "unstructured": "Wirtenberger M, Frank B, Hemminki K et al (2006) Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancer. Carcinogenesis 8:1655–1660",
      "volume": "8",
      "year": "2006"
    }
  ],
  "reference-count": 90,
  "references-count": 90,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-007-9172-6"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Hereditary diffuse gastric cancer: association with lobular breast cancer"
  ],
  "type": "journal-article",
  "volume": "7"
}